Type
1.
Aquaron R, Lund P, Baker C. [A case for the inclusion of oculocutaneous albinism as a skin-related Neglected Tropical Disease]. Medecine tropicale et sante internationale [Internet]. 2023;3(4):1-13. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/38390024/
Type
1.
Medeiros C de A Universidade de Pernambuco, Brazil; Universidade de Pernambuco, Brazil; Universidade de Pernambuco, Brazil, Silva MB de A Universidade de Pernambuco, Brazil, Oliveira ALS de Fundação Oswaldo Cruz, Brazil, Alves SMM Universidade de Pernambuco, Brazil, Barros M das ND da S Universidade de Pernambuco, Brazil, Cavalcanti M da GA de M Universidade de Pernambuco, Brazil, et al. Mapping the morbidity and mortality of Chagas disease in an endemic area in Brazil. Revista do Instituto de Medicina Tropical de São Paulo [Internet]. 2022;64. Available from: https://www.scielo.br/j/rimtsp/a/pmjqNjTPyp7nfC39wSHZx5q/?format=pdf&lang=en
Type
1.
Atram MA, Ghongade P V, Gangane NM. A Clinicohistopathological Correlation of Hansen’s Disease in a Rural Tertiary Care Hospital of Central India. Journal of global infectious diseases [Internet]. 2020;12(4):191-6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8045542/
Type
1.
Abudho BO, Guyah B, Ondigo BN, Ndombi EM, Ireri E, Carter JM, et al. Evaluation of morbidity in Schistosoma mansoni-positive primary and secondary school children after four years of mass drug administration of praziquantel in western Kenya. Infectious diseases of poverty [Internet]. 2020;9(1):67. Available from: https://link.springer.com/content/pdf/10.1186/s40249-020-00690-7.pdf
Type
1.
Rajput CD, Nikam BP, Gore SB, Malani SS. Nail Changes in Leprosy: An Observational Study of 125 Patients. Indian dermatology online journal. 2020;11(2):195-201.
Type
1.
Mphande FA. Skin Diseases: Need for Attention. In: Skin Disorders in Vulnerable Populations. Springer Singapore; 2020. pp. 1-12.
Type
1.
Mphande FA. Impact of Skin Diseases in Limited Resource Countries. In: Skin Disorders in Vulnerable Populations. Springer Singapore; 2020. pp. 65-72.
Type
1.
King CH, Binder S, Shen Y, Whalen CC, Campbell CH, Wiegand RE, et al. SCORE Studies on the Impact of Drug Treatment on Morbidity due to and Infection. The American journal of tropical medicine and hygiene [Internet]. 2020;. Available from: http://www.ajtmh.org/docserver/fulltext/10.4269/ajtmh.19-0830/tpmd190830.pdf?expires=1589982345&id=id&accname=guest&checksum=C408B9FD41FC8B33C2DD1073F47C505F
Type
1.
Kura K, Collyer BS, Toor J, Truscott JE, Hollingsworth D, Keeling MJ Zeeman Institute (SBIDER), University of Warwick, Mathematical Sciences Building, Gibbet Hill Road, Coventry, CV4 7AL, UK, et al. Policy implications of the potential use of a novel vaccine to prevent infection with Schistosoma mansoni with or without mass drug administration. Vaccine [Internet]. 2020;. Available from: https://reader.elsevier.com/reader/sd/pii/S0264410X20306058?token=A785007831F75B9701051B59E588587B1D2F229C9B368D48B51EAD97E532E3427A5E1812729B03367979666EE63B19FD
Type
1.
Colebunders R, Stolk W, Siewe Fodjo JN, Mackenzie C, Hopkins A. Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions. Infectious diseases of poverty [Internet]. 2019;8(1):83. Available from: https://idpjournal.biomedcentral.com/track/pdf/10.1186/s40249-019-0593-x